FOLH1 and neoplasm: In a subsequent therapy study on mice, it was reported that the increased tumor retention of 177Lu-labeled Ibu-DAB-PSMA and PSMA-ALB-56 resulted in better therapeutic efficacy compared to PSMA-617.